Links to other pages within Patient UK which are related to this topic:
Experience | Leaflets | Patient+ | Guidelines | Weblinks | Poems | News | Products | Other
Print options:   Other options:   Bookmark and Share

This is a PatientPlus article. PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

This disease is notifiable in the UK under the Public Health (Infectious Diseases) Regulations 1988.

Measles is the archetypal childhood infection - whilst self-limiting in most, it is not a trivial disease with complications in about 10% requiring hospital admission and fatality rates of 1 per 5,000 in the UK (higher rates in other industrialised countries).

Immunisation programmes in the UK and elsewhere had limited many modern clinicians' exposure to the disease. Falls in the uptake of immunisation over the last decade has now increased the susceptible population to such a degree that measles is again endemic here1. There is concern that conditions could permit a large epidemic outbreak in England, with estimates of 30,000 cases in children and young adults affected (or in the worst case scenario, more than 100,000 cases).2,3

Epidemiology4

Measles is an acute infection caused by a single stranded RNA Morbillivirus from the paramyxovirus family. It is highly contagious. Transmission is airborne via respiratory droplets. These spread to surfaces and virus can remain transmissible for up to 2 hours removing the need for direct person-to-person contact.

The infection has an average incubation period of 14 days (range 6-19 days) and infectivity lasts from 2-4 days prior to 2-5 days following the onset of the rash.5

  • Infection traditionally has occurred within 3 and 6 years of age on starting education. However, transmission is uncommon in vaccinated school age children but younger children and susceptible adults are at risk.
  • Disease mainly occurs in winter and spring with an outbreak every other year.
  • In England and Wales, there were 1,217 cases of confirmed measles between January and the end of November 2008, the highest for 13 years.6 There has also been the first measles related death since 1992, in 2006. Poor uptake of MMR followed controversy surrounding the vaccination and an unproven link with autism.
  • Other European countries with endemic measles include Romania, Germany, Switzerland and Italy. Between 2006-7, there were 12,132 confirmed cases of measles across Europe.7 Most were in unvaccinated or incompletely vaccinated children but almost a fifth were aged 20 years or older. Seven measles-related deaths were recorded over the same time period. This makes WHO's target for elimination of measles in the European region by 2010 seem doubtful.8
  • In the US measles has been eradicated since 2002.
Presentation4
  • Prodrome:
    • Lasts 2-4 days with fever, runny nose, mild conjunctivitis and diarrhoea.
    • Koplik spots are pathognomic and appear on the buccal mucosa opposite the second molar teeth as small, red spots each with a bluish-white speck (sometimes compared to a grain of rice) in the centre.9 They occur in 60-70% of patients during the prodrome and for up to 2-3 days before the onset of the rash.
  • Rash (morbilliform = measles-like):
    • First seen on forehead and neck and spreads, involves trunk and finally limbs over 3-4 days. It may become confluent in some areas.
    • Rash then fades after 3-4 days in the order of its appearance.
    • It leaves behind a brownish discoloration sometimes accompanied by fine desquamation.
  • Often high fever (may be >40°C), non-productive cough, patient clearly ill.
  • Also, swelling around eyes and photophobia.

Clinical recovery in uncomplicated measles tends to occur soon after the appearance of the rash.

Investigations

WHO recommended clinical case definition:10

  • Any person in whom a clinician suspects measles infection.
  • Any person with fever and maculopapular rash (i.e. non-vesicular) and cough, coryza (i.e. runny nose) or conjunctivitis (i.e. red eyes).

Case definition of measles helps identify cases for notification but clinical diagnosis is unreliable, particularly in countries with low incidence of disease, so laboratory confirmation is required.

Laboratory diagnosis of measles:

  • Salivary swab or serum sample for measles specific IgM taken within 6 weeks of onset.
  • RNA detection in salivary swabs or other samples.
  • Additional tests include buccal scrapings stained with Leishman's and examined under microscope for giant cells and immunofluorescence of an NPA (nasopharyngeal aspirate) sample.
Management
  • Uncomplicated measles is usually self-limiting and treatment is mainly symptomatic with paracetamol or ibuprofen and plenty of fluids. Patients should remain at home to limit disease spread.
  • Monitor carefully for signs of complications and consider hospitalisation if they appear.

Measles is a notifiable disease in England and Wales and every suspected case should be notified to enable confirmation of diagnosis and public health management of outbreaks

Complications4,11

Rates of complications vary by age, geographical region and outbreak. They increase where there is co-existent immunodeficiency, malnutrition, vitamin A deficiency and high exposure levels due to overcrowding.

Respiratory

  • Bronchopneumonia occurs in up to 5% cases producing serious respiratory difficulties and accounts for 56-86% deaths. Infecting organism is usually Staph. aureus or secondary viral infection with Herpes simplex or adenovirus. Lobar pneumonia can occur and is caused by Strep. pneumoniae. Other secondary bacterial infections include cervical adenitis and otitis media. Lobar pneumonia should be treated with benzylpenicillin and bronchopneumonia with gentamicin, cloxacillin or co-trimoxazole.
  • Giant cell pneumonitis in immunocompromised patients presents 2-3 weeks following measles infection with worsening breathing.

Neurological

Measles is associated with 3 different encephalitic diseases.

  • Acute demyelinating encephalitis - occurs in 1-2/1000 cases of infection. Occurs within 2 weeks of the rash appearing usually with seizures often accompanied by fever, irritability, headache and changing consciousness that may progress to coma. Believed to be a neuroallergic process. Carries a 10-15% mortality rate with 25% children with permanent brain damage. Treatment is supportive with no clear benefit from dexamethasone.
  • Subacute sclerosing panencephalitis - occurs in 0.1-1.4/million children infected. Commoner in boys and where the initial infection occurs before the age of 2, onset is usually 5-10 years after apparently normal measles, with disturbance in intellect and personality, behavioural disorders and worsening school work. This is followed by seizures, signs of extrapyramidal and pyramidal disease and finally decerebrate rigidity and death. Condition is untreatable.
  • Measles inclusion body encephalitis - occurs in the immunocompromised 1-7 months following exposure and is progressive over months. It is largely fatal and of the approximately 15% survivors, all will have neurological sequelae.

Gastrointestinal

Measles is commonly accompanied by diarrhoea due to secondary bacterial or protozoal infections. This is particularly significant in malnourished individuals. Clinical hepatitis and hypocalcaemia may also occur, more usually in adults.

Vitamin A deficiency and blindness

Those with borderline vitamin A deficiency may have frank vitamin A deficiency precipitated by measles. This usually manifests itself as xerophthalmia and is an important cause of blindness worldwide. WHO recommends high dose vitamin A for all children with measles in countries where the case fatality rate is greater than 1%.

Immunodeficiency

Infants and adults show delayed recovery from the lymphopenia that measles infection causes. Even after lymphocyte counts have normalised, immunodeficiency persists for many weeks and this is thought to be a major contributor to the high all cause mortality following acute measles world-wide.

Obstetric

Like many infections, measles can be more severe in pregnancy as a potentially fatal pneumonitis may follow. Measles is also associated with increased risk of miscarriage, prematurity, low birthweight but not congenital malformation.

Prognosis

Disease severity varies from mild (usually in the well-fed child) to severe (usually in the malnourished or immunosuppressed patient). However, severe measles can occasionally present in a previously healthy child and particularly in young adults who have not been vaccinated or exposed to the virus naturally.

  • In the West mortality is <0.05% cases.
  • Worldwide measles is responsible for >1 million deaths often due to pneumonia as a secondary bacterial infection and is the leading cause of vaccine preventable death.
  • Complication and mortality rates are highest in infancy and lowest in 1-9 year olds, before rising again into adulthood.
Prevention

Vaccination12,13

  • Currently use live strains attenuated by culture in chick fibroblasts.
  • In developed world given at 14-16 months after maternal antibody that neutralizes the virus has disappeared.
  • In developing world WHO recommends vaccination at 9 months when it has been shown to produce a significant reduction in all all-cause mortality greater than would be expected from merely preventing measles.12

Indications

  • In UK given as part of MMR vaccination at around 13 months as seroconversion at this age is better than in younger children. A pre-school booster is required. Note that in developing countries where measles mortality is high, measles vaccine is given between 6 and 9 months but vaccine failure is more common.
  • Older children and adults thought to be susceptible should receive 1 or 2 doses as required. Ideally the second dose should be given after 3 months but where protection is urgently needed, the second can be given a month following the first.
  • Currently (2008-9), there is a MMR catch-up programme running in England and Wales to try to limit the risk of an epidemic outbreak. Target groups in order of priority are:2
    • Those aged 13 months to 18 years who have not received any MMR vaccine.
    • Partially immunised children aged 3 years 7 months (in September 2008) to 11 years.
    • Partially immunised children aged 12 to 18 years (school years 8 to 13).
    • Partially immunised individuals over 18 years leaving school to go to higher education or other further education establishments.
  • HIV positive individuals should also receive MMR provided they are not too severely immunocompromised.

Contraindications

  • Pregnant women
  • Immunocompromised individuals
  • Confirmed prior anaphylactic reaction to any of the viral vaccine components or to neomycin or gelatin

Post-exposure prophylaxis

  • MMR vaccination may be effective if given to susceptibles (over 9 months old) if given within 72 hours of exposure.
  • Human normal immunoglobulin should be considered within 5 days of exposure for severely immunocompromised individuals, pregnant women negative for measles IgG and those aged less than 9 months.


Document references
  1. No authors listed; Measles once again endemic in the United Kingdom. Euro Surveill. 2008 Jul 3;13(27). pii: 18919.
  2. The MMR vaccination catch-up programme, CMO letter, (2008) PL/CMO/2008/5
  3. Choi YH, Gay N, Fraser G, et al; The potential for measles transmission in England. BMC Public Health. 2008 Sep 26;8:338. [abstract]
  4. HPA Measles; General information and up-to-date current statistics.
  5. de Swart RL; The pathogenesis of measles revisited. Pediatr Infect Dis J. 2008 Oct;27(10 Suppl):S84-8. [abstract]
  6. Kmietowicz Z; Cases of measles in England and Wales are highest for 13 years. BMJ. 2008 Dec 1;337:a2820. doi: 10.1136/bmj.a2820.
  7. Muscat M, Bang H, Wohlfahrt J, et al; Measles in Europe: an epidemiological assessment. Lancet. 2009 Jan 6. [abstract]
  8. WHO measles; World Health Organisation: Measles; worldwide epidemiology and targets
  9. Koplik Spot; University of Leeds Dentistry department website: Viral infections; Image of typical koplik spot
  10. WHO Recommended surveillance standard of measles
  11. Asaria P, MacMahon E; Measles in the United Kingdom: can we eradicate it by 2010? BMJ. 2006 Oct 28;333(7574):890-5.
  12. Shann F; A little bit of measles does you good. Even if measles is eradicated, immunisation may still be desirable in developing countries. BMJ. 1999 Jul 3;319(7201):4-5.
  13. Immunisation Green book website

Internet and further reading
  • DOH; Immunisation - MMR; Information for parents and professionals.
  • DermIS; Dermatology Information System - Measles; Images of measles rash.
  • No authors listed; Progress in global measles control and mortality reduction, 2000-2007. MMWR Morb Mortal Wkly Rep. 2008 Dec 5;57(48):1303-6.
Acknowledgements EMIS is grateful to Dr Chloe Borton for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2009.
Document ID: 2441
Document Version: 22
Document Reference: bgp391
Last Updated: 6 Feb 2009
Planned Review: 6 Feb 2011

The authors and editors of this article are employed to create accurate and up to date content reflecting reliable research evidence, guidance and best clinical practice. They are free from any commercial conflicts of interest. Find out more about updating.

Links to other pages within Patient UK which are related to this topic:
Experience | Leaflets | Patient+ | Guidelines | Weblinks | Poems | News | Products | Other
Print options:   Other options:   Bookmark and Share
Want to search some more? Use the Google Search box below to search our site.

Related pages in Patient UK

Your Experience (^ top of page)

 Please add your experience about this condition / medicine
 View Patient Experience for 'Measles' (5 there)
 Measles
 MMR Immunisation

 Measles Mumps and Rubella (MMR) Immunisation
 Notifiable Diseases

 Guidelines on Measles

 Measles

 Maisie's Measles

Recent related news items

 Vaccination warning as measles on the rise
 Measles kills children of anti-vaccination sect
 Global Measles Deaths Drop By 78%, But Resurgence Likely
 Parents make MMR a priority as new term begins
 Measles update for 17 August 2009

All news by related topic

 Measles news

Medical equipment


Visit the Patient UK Medical Equipment shop

Books


Visit the Patient UK shop

Other - Useful resources (^ top of page)

Pictures, diagrams, photos, images, etc.
Evidence based medicine
Online textbooks and journals
UK Guidelines
Online Videos
Medline
Other good health sites

Want to search some more? Use the Google Search box below to search our site.

Advertisements















Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.

Want to advertise on this site? Find out how >>

Clicking here will take you to the foot of this page where you'll find a list of Information Leaflets which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Support Groups which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Medicines & Drugs which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of diagrams which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of PatientPlus (detailed reference) articles which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of UK Guidelines which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of other selected websites which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Poems and Stories which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Operations and Procedures which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Online Videos which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find links through to our interactive forum.
Here you can follow a link to view existing patient experiences on this subject, or to add your own
Clicking here will take you to the foot of this page where you'll find links to news stories on this subject in our Online Newspaper
Clicking here will take you to the foot of this page where you'll find links to related products
Clicking here will take you to the foot of this page where you'll find links to other useful sources of information
Click here to open a printer-friendly version of this document, in a new window, together with the print dialogue box
Click here to open this document in PDF format
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Click here to listen to the MP3 audio recording of this document
Click here to download the audio recording of this document as a podcast, for listening to at your leisure
Click here to open our Dictionaries and Glossaries page
Click here to see related products in our Online Pharmacy
Note: this will open in a new window
Click here to add this page to a social bookmarking site of your choice
Click here if you want to find out more about social bookmarking. This link will take you to the Wikipedia explanation
Note: this will open in a new window
Clicking here will take you to the foot of this page where you'll find a list of Information Leaflets which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Support Groups which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Medicines & Drugs which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of diagrams which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of PatientPlus (detailed reference) articles which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of UK Guidelines which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of other selected websites which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Poems and Stories which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Operations and Procedures which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Online Videos which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find links through to our interactive forum.
Here you can follow a link to view existing patient experiences on this subject, or to add your own
Clicking here will take you to the foot of this page where you'll find links to news stories on this subject in our Online Newspaper
Clicking here will take you to the foot of this page where you'll find links to related products
Clicking here will take you to the foot of this page where you'll find links to other useful sources of information
Click here to open a printer-friendly version of this document, in a new window, together with the print dialogue box
Click here to open this document in PDF format
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Click here to listen to the MP3 audio recording of this document
Click here to download the audio recording of this document as a podcast, for listening to at your leisure
Click here to open our Dictionaries and Glossaries page
Click here to see related products in our Online Pharmacy
Note: this will open in a new window
Click here to add this page to a social bookmarking site of your choice
Click here if you want to find out more about social bookmarking. This link will take you to the Wikipedia explanation
Note: this will open in a new window
Click here to return to the home page
Click here to read our 'About Us' page
Go to the Emis Access website, where you can book an appointment with your GP, order a repeat prescription or view you medical record online.
Note: this will open in a new window
View and/or join in discussion about health, lifestyle and disease in our interactive forum.
Note: this will open in a new window
Visit our pharmacy product price comparison website
Go to our online newspaper for current medical news and commentary.
Note: this will open in a new window
Adverts on this site do not influence the medical content. Click to read more.
Adverts on this site do not influence the medical content. Click to read more.
This organsition has been certified as a producer of reliable health and social care information.

Click the image to find out more.